IONQ Inc vs QXO Inc. Common Stock — how do they compare? IONQ Inc trades at $30.94 (market cap $14.07B), while QXO Inc. Common Stock trades at $10.36 (market cap $11.43B). The key difference: IONQ Inc is the larger of the two by market cap, and IONQ Inc is more actively traded (23,412,195 versus 21,645,941). Which is the better fit depends on your goals — on Pluang, investors hold IONQ Inc for 34 Days and QXO Inc. Common Stock for 0 Days on average.
| IONQ | QXO | |
|---|---|---|
Market Cap | $14.07B | $11.43B |
Volume | 23,412,195 | 21,645,941 |
Sector | Technology | Industrials |
52-Week High | $72.41 | $27.07 |
52-Week Low | $26.59 | $10.33 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $12.01B | $16.75B |
Signals from Pluang's Aura AI — not financial advice
IONQ trades at $34.73, down 4.25% today, with a bearish technical signal despite recent earnings beats. The quantum computing company shows explosive revenue growth (2025: $130M, 2026: $246M) but faces significant profitability challenges with a -553% net income margin. Analyst consensus is split with a $65.20 price target suggesting 88% upside potential, while technical indicators show oversold conditions with RSI at 26.86.
The stock presents high-risk, high-reward potential with Wall Street divided on its path to profitability. Key catalysts include quantum technology adoption and manufacturing scaling, while risks center on cash burn and competitive threats in the emerging quantum computing space.
QXO trades at $11.02, up 3.57% on the day but down significantly year-to-date amid weak residential demand and integration challenges from its TopBuild acquisition. The stock shows neutral technical signals with support near $10-$11 and resistance at $12. Fundamentally, revenue grew to $6.84B in 2025 but net losses deepened to $279.4M, with a negative profit margin of -5.17% in 2026. Analyst sentiment remains bullish with a $22.89 consensus target, though recent news highlights margin pressure and execution risks.
The outlook hinges on successful integration of acquisitions and EBITDA growth targets, but high execution risk, negative earnings, and sector headwinds pose substantial downside. With 100% buy ratings from analysts and institutional accumulation, patient investors may see upside if management delivers on its playbook, though volatility is expected near-term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →QXO, Inc. is a distributor of roofing, insulation, waterproofing, and other building materials, serving contractors and builders across US and Canada through its network of branch locations.
Read more on QXO →